Screener
Acadia Pharmaceuticals ACAD Common Stock
Common Stock at other companies
Other financials
Where this comes from
Reported directly by Acadia Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:CommonStockValue.
The source filing: Acadia Pharmaceuticals’s 10-Q, filed August 5, 2026.
- Filed
- Aug 4, 2026, 8:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-333243
| Line item | June 30,2026 | December 31,2025 |
|---|---|---|
| Commitments and contingencies (Note 9) | ||
| Stockholders’ equity: | ||
| Preferred stock, $0.0001 par value; 5,000,000 shares authorized at June 30, 2026 and December 31, 2025; no shares issued and outstanding at June 30, 2026 and December 31, 2025 | — | — |
| Common stock, $0.0001 par value; 225,000,000 shares authorized at June 30, 2026 and December 31, 2025; 172,132,442 shares and 170,309,376 shares issued and outstanding at June 30, 2026 and December 31, 2025, respectively | 16 | 16 |
| Additional paid-in capital | 3,085,800 | 3,039,315 |
| Accumulated deficit | (1,778,249) | (1,813,386) |
| Accumulated other comprehensive (loss) income | (958) | 1,445 |
| Total stockholders’ equity | 1,306,609 | 1,227,390 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Acadia Pharmaceuticals's common stock?
- Acadia Pharmaceuticals (ACAD) reported common stock of $16K in Q2 2026.
- How has Acadia Pharmaceuticals's common stock changed year-over-year?
- Acadia Pharmaceuticals's common stock decreased by 0.0% year-over-year, from $16K to $16K.
- What is the long-term trend for Acadia Pharmaceuticals's common stock?
- Over 5 years (2020 to 2025), Acadia Pharmaceuticals's common stock has grown at a 0.0% compound annual growth rate (CAGR), from $16K to $16K.
- What does common stock mean?
- The par value of all common shares issued and outstanding, typically a nominal amount ($0.01 or $0.001 per share).
Ask your AI about Acadia Pharmaceuticals's common stock.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude